For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Relay Therapeutics, Inc.

USPTO Granted Patents = 12

EPO Patents = 4

Trademarks = 8

Forward Citations = 25

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Fabrizio Giordanetto (10 out of 10 patents)

Alexander M Taylor (9 out of 27 patents)

André Lescarbeau (8 out of 11 patents)

4. W Patrick Walters (7 out of 8 patents)

5. Mark Andrew Murcko (6 out of 56 patents)

6. Kelley C Shortsleeves (6 out of 7 patents)

7. Eric Therrien (6 out of 8 patents)

8. Elizabeth Helen Kelley (5 out of 9 patents)

9. Jack Benjamin Greisman (4 out of 4 patents)

10. Paul Maragakis (4 out of 6 patents)

11. Thomas H McLean (3 out of 14 patents)

12. Sathesh P Bhat (3 out of 10 patents)

13. Markus Kristofer Dahlgren (3 out of 8 patents)

14. Lucian V DiPietro (2 out of 24 patents)

15. Hakan Gunaydin (2 out of 15 patents)

12 patents: Sort by Forward Citations

1. 12331056 - SHP2 phosphatase inhibitors and methods of use thereof (2025-06-17),

2. 12219327 - Substituted isoindolines as PI3K-alpha inhibitors (2025-02-04),

3. 12152034 - FGFR inhibitors and methods of making and using the same (2024-11-26),

4. 12138263 - Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof (2024-11-12),

5. 12084447 - SHP2 phosphatase inhibitors and methods of use thereof (2024-09-10),

6. 11890281 - SHP2 phosphatase inhibitors and methods of making and using the same (2024-02-06),

7. 11780845 - FGFR inhibitors and methods of use thereof (2023-10-10),

8. 11701354 - Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors (2023-07-18),

9. 11629145 - SHP2 phosphatase inhibitors and methods of use thereof (2023-04-18),

10. 11591336 - Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors (2023-02-28),

11. 11529347 - SHP2 phosphatase inhibitors and methods of use thereof (2022-12-20),

12. 10934302 - SHP2 phosphatase inhibitors and methods of use thereof (2021-03-02),

Relay Therapeutics is a biotechnology company that is pioneering a new approach to drug discovery. Using cutting-edge technology, including computational simulations and machine learning, Relay Therapeutics aims to accelerate the development of precision medicines for patients with cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#177 in Cambridge, MA

#1,503 in Massachusetts

#24,828 in US

#46,735 in the World

Cambridge, MA, United States of America

Relay Therapeutics, Inc.

Forward Citations = 25

38 inventors:

Fabrizio Giordanetto (10 out of 10 patents)

Alexander M Taylor (9 out of 27 patents)

André Lescarbeau (8 out of 11 patents)

4. W Patrick Walters (7 out of 8 patents)

5. Mark Andrew Murcko (6 out of 56 patents)

Please report any incorrect information to support@idiyas.com

Loading…